Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,313,684
-
Share change
-
+289,755
-
Total reported value
-
$46,330,666
-
Price per share
-
$2.84
-
Number of holders
-
41
-
Value change
-
+$1,003,639
-
Number of buys
-
21
-
Number of sells
-
18
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q3 2023
As of 30 Sep 2023 CYTEIR THERAPEUTICS INC - COM (CYTT) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,313,684 shares of stock of the company.
Largest 10 holders included BML Capital Management, LLC, Newtyn Management, LLC, OUP Management Co., LLC, Anson Funds Management LP, VR Advisory Services Ltd, FMR LLC, Novo Holdings A/S, VANGUARD GROUP INC, GABELLI FUNDS LLC, and GABELLI & Co INVESTMENT ADVISERS, INC..
This table shows 41 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.